SGMT Financial Statements

Balance sheet, income statement, cash flow, and dividends for Sagimet Biosciences Inc (SGMT).


$144.88M Market Cap.

As of 03/12/2025 5:00 PM ET (MRY) • Disclaimer

SGMT Market Cap. (MRY)


SGMT Shares Outstanding (MRY)


SGMT Assets (MRY)


Total Assets

$160.26M

Total Liabilities

$4.45M

Total Investments

$82.82M

SGMT Income (MRY)


Revenue

$0

Net Income

-$45.57M

Operating Expense

$54.45M

SGMT Cash Flow (MRY)


CF Operations

-$42.44M

CF Investing

-$61.68M

CF Financing

$104.82M

SGMT Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

-

0%

0%

-

2021

$0

-

-

0%

-

SGMT Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$160,259,000 (65.70%)

$96,719,000 (192.81%)

$33,031,000 (-44.05%)

$59,032,000

Assets Current

$152,774,000 (58.08%)

$96,646,000 (194.72%)

$32,792,000 (-44.10%)

$58,663,000

Assets Non-Current

$7,485,000 (10153.42%)

$73,000 (-69.46%)

$239,000 (-35.23%)

$369,000

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0

Shareholders Equity

$155,805,000 (71.09%)

$91,065,000 (148.71%)

-$186,950,000 (-18.13%)

-$158,259,000

Property Plant & Equipment Net

$77,000 (5.48%)

$73,000 (-65.57%)

$212,000 (-38.01%)

$342,000

Cash & Equivalents

$75,840,000 (0.93%)

$75,139,000 (40515.68%)

$185,000 (-99.67%)

$56,758,000

Accumulated Other Comprehensive Income

$230,000 (666.67%)

$30,000 (135.71%)

-$84,000 (0%)

$0

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0

Total Investments

$82,818,000 (319.16%)

$19,758,000 (-38.61%)

$32,187,000 (0%)

$0

Investments Current

$75,410,000 (281.67%)

$19,758,000 (-38.61%)

$32,187,000 (0%)

$0

Investments Non-Current

$7,408,000 (0%)

$0 (0%)

$0 (0%)

$0

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$0

Trade & Non-Trade Payables

$1,425,000 (666.13%)

$186,000 (-83.47%)

$1,125,000 (47.83%)

$761,000

Accumulated Retained Earnings (Deficit)

-$295,311,000 (-18.25%)

-$249,744,000 (-12.56%)

-$221,868,000 (-15.94%)

-$191,369,000

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0

Total Debt

$78,000 (20.00%)

$65,000 (-69.19%)

$211,000 (-39.37%)

$348,000

Debt Current

$78,000 (20.00%)

$65,000 (-51.13%)

$133,000 (7.26%)

$124,000

Debt Non-Current

$0 (0%)

$0 (0%)

$78,000 (-65.18%)

$224,000

Total Liabilities

$4,454,000 (-21.22%)

$5,654,000 (5.47%)

$5,361,000 (100.71%)

$2,671,000

Liabilities Current

$4,454,000 (-21.22%)

$5,654,000 (7.10%)

$5,279,000 (116.35%)

$2,440,000

Liabilities Non-Current

$0 (0%)

$0 (0%)

$82,000 (-64.50%)

$231,000

SGMT Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$2,000,000 (0%)

$0 (0%)

$0

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0

Selling General & Administrative Expense

$16,010,000 (23.51%)

$12,963,000 (111.26%)

$6,136,000 (40.12%)

$4,379,000

Research & Development Expense

$38,444,000 (94.39%)

$19,777,000 (-20.63%)

$24,919,000 (28.85%)

$19,340,000

Operating Expenses

$54,454,000 (66.32%)

$32,740,000 (5.43%)

$31,055,000 (30.93%)

$23,719,000

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0

Consolidated Income

-$45,567,000 (-63.46%)

-$27,876,000 (8.60%)

-$30,499,000 (-24.78%)

-$24,442,000

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0

Net Income

-$45,567,000 (-63.46%)

-$27,876,000 (8.60%)

-$30,499,000 (-24.78%)

-$24,442,000

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0

Net Income Common Stock

-$45,567,000 (-63.46%)

-$27,876,000 (8.60%)

-$30,499,000 (-24.78%)

-$24,442,000

Weighted Average Shares

$31,350,725 (199.71%)

$10,460,335 (-28.71%)

$14,673,342 (50.61%)

$9,742,682

Weighted Average Shares Diluted

$31,350,725 (199.71%)

$10,460,335 (-28.71%)

$14,673,342 (50.61%)

$9,742,682

Earning Before Interest & Taxes (EBIT)

-$45,567,000 (-63.46%)

-$27,876,000 (8.60%)

-$30,499,000 (-24.78%)

-$24,442,000

Gross Profit

$0 (0%)

$2,000,000 (0%)

$0 (0%)

$0

Operating Income

-$54,454,000 (-77.14%)

-$30,740,000 (1.01%)

-$31,055,000 (-30.93%)

-$23,719,000

SGMT Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$61,683,000 (-590.33%)

$12,580,000 (139.30%)

-$32,010,000 (0%)

$0

Net Cash Flow from Financing

$104,819,000 (21.65%)

$86,167,000 (118136.99%)

-$73,000 (-100.75%)

$9,739,000

Net Cash Flow from Operations

-$42,435,000 (-78.55%)

-$23,766,000 (2.96%)

-$24,490,000 (-12.81%)

-$21,710,000

Net Cash Flow / Change in Cash & Cash Equivalents

$701,000 (-99.07%)

$74,981,000 (232.54%)

-$56,573,000 (-372.58%)

-$11,971,000

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0

Net Cash Flow - Investment Acquisitions and Disposals

-$61,683,000 (-590.33%)

$12,580,000 (139.30%)

-$32,010,000 (0%)

$0

Capital Expenditure

$0 (0%)

$0 (0%)

$0 (0%)

$0

Issuance (Repayment) of Debt Securities

-$1,045,000 (70.30%)

-$3,518,000 (-4038.82%)

-$85,000 (93.22%)

-$1,254,000

Issuance (Purchase) of Equity Shares

$105,864,000 (18.04%)

$89,685,000 (747275.00%)

$12,000 (-93.65%)

$189,000

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0

Share Based Compensation

$5,288,000 (5.97%)

$4,990,000 (165.43%)

$1,880,000 (-1.26%)

$1,904,000

Depreciation Amortization & Accretion

$145,000 (4.32%)

$139,000 (6.92%)

$130,000 (-2.99%)

$134,000

SGMT Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

100.00%

-

-

Profit Margin

-

-1393.80%

-

-

EBITDA Margin

-

-1386.80%

-

-

Return on Average Equity (ROAE)

-26.00% (-147.10%)

55.20% (211.86%)

17.70%

-

Return on Average Assets (ROAA)

-25.40% (43.43%)

-44.90% (32.28%)

-66.30%

-

Return on Sales (ROS)

-

-1393.80%

-

-

Return on Invested Capital (ROIC)

-66.40% (88.24%)

-564.60% (-158.75%)

-218.20%

-

Dividend Yield

0% (0%)

0%

-

-

Price to Earnings Ratio (P/E)

-3.1 (-52.26%)

-2.04

-

-

Price to Sales Ratio (P/S)

-

28.35

-

-

Price to Book Ratio (P/B)

0.93 (-31.77%)

1.36

-

-

Debt to Equity Ratio (D/E)

0.03 (-53.23%)

0.06 (313.79%)

-0.03 (-70.59%)

-0.02

Earnings Per Share (EPS)

-1.45 (45.49%)

-2.66 (-27.88%)

-2.08 (17.13%)

-2.51

Sales Per Share (SPS)

0 (0%)

0.19 (0%)

0 (0%)

0

Free Cash Flow Per Share (FCFPS)

-1.35 (40.40%)

-2.27 (-36.13%)

-1.67 (25.09%)

-2.23

Book Value Per Share (BVPS)

4.97 (-42.91%)

8.71 (168.33%)

-12.74 (21.56%)

-16.24

Tangible Assets Book Value Per Share (TABVPS)

5.11 (-44.71%)

9.25 (310.75%)

2.25 (-62.85%)

6.06

Enterprise Value Over EBIT (EV/EBIT)

-1 (0.00%)

-1

-

-

Enterprise Value Over EBITDA (EV/EBITDA)

-1.5 (-85.73%)

-0.81

-

-

Asset Turnover

0 (0%)

0.03 (0%)

0

-

Current Ratio

34.3 (100.67%)

17.09 (175.16%)

6.21 (-74.16%)

24.04

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0

Free Cash Flow (FCF)

-$42,435,000 (-78.55%)

-$23,766,000 (2.96%)

-$24,490,000 (-12.81%)

-$21,710,000

Enterprise Value (EV)

$67,981,052 (204.07%)

$22,356,735

-

-

Earnings Before Tax (EBT)

-$45,567,000 (-63.46%)

-$27,876,000 (8.60%)

-$30,499,000 (-24.78%)

-$24,442,000

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$45,422,000 (-63.76%)

-$27,737,000 (8.67%)

-$30,369,000 (-24.93%)

-$24,308,000

Invested Capital

$80,043,000 (400.55%)

$15,991,000 (-42.43%)

$27,778,000 (15162.64%)

$182,000

Working Capital

$148,320,000 (63.00%)

$90,992,000 (230.72%)

$27,513,000 (-51.06%)

$56,223,000

Tangible Asset Value

$160,259,000 (65.70%)

$96,719,000 (192.81%)

$33,031,000 (-44.05%)

$59,032,000

Market Capitalization

$144,879,052 (16.75%)

$124,095,735

-

-

Average Equity

$174,949,500 (446.14%)

-$50,543,250 (70.72%)

-$172,604,500

-

Average Assets

$179,645,500 (189.29%)

$62,098,750 (34.90%)

$46,031,500

-

Invested Capital Average

$68,645,250 (1290.42%)

$4,937,000 (-64.69%)

$13,980,000

-

Shares

32,195,345 (40.62%)

22,895,892 (35.78%)

16,862,231

-